Prentiss Christopher B

CIK 00017175832 companiesDANBURY, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001717583

Recent Transactions

34 trades

Award
MANNKIND CORP$MNKD
Employee Stock Option (right to buy)
2026-03-23+217,000→ 217,000 total
Award
MANNKIND CORP$MNKD
Performance Restricted Stock Unit
2026-03-23+221,000→ 221,000 total
Award
MANNKIND CORP$MNKD
Common Stock, $0.01 Par Value
2026-03-01$3.27/sh+5,000→ 348,854 total
Tax Payment
MANNKIND CORP$MNKD
Common Stock, $0.01 Par Value
2025-07-15$3.85/sh−11,540→ 343,854 total
Award
MANNKIND CORP$MNKD
Performance Restricted Stock Unit
2025-05-13+145,000→ 145,000 total
Award
MANNKIND CORP$MNKD
Common Stock, $0.01 Par Value
2025-05-13+119,000→ 353,193 total
Award
MANNKIND CORP$MNKD
Common Stock, $.01 Par Value
2024-05-15+103,600→ 103,600 total
Award
MANNKIND CORP$MNKD
Common Stock, $.01 Par Value
2024-05-15+129,000→ 232,600 total
Award
MANNKIND CORP$MNKD
Performance Restricted Stock Unit
2024-05-15+158,000→ 158,000 total
Award
MANNKIND CORP$MNKD
Common Stock, $.01 Par Value
2024-05-15+103,600→ 103,600 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−163,767→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−37,500→ 0 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−50,000→ 0 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24+18,750→ 163,767 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2021-03-22$5.48/sh−2,422→ 145,017 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-03-02+75,000→ 147,439 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2021-02-01$6.36/sh−3,821→ 72,439 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2021-01-20$4.41/sh−2,630→ 76,260 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2020-11-02$3.21/sh−2,050→ 78,890 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2020-03-17+10,000→ 80,940 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2020-01-21$5.92/sh−1,269→ 70,940 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2019-11-07+25,000→ 72,209 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2019-11-07+50,000→ 50,000 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2019-07-22$6.00/sh−1,082→ 47,209 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2019-04-08+18,750→ 48,291 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2019-04-08+37,500→ 37,500 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2019-03-20$8.00/sh−1,185→ 29,541 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2018-12-27+12,500→ 30,726 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2018-12-20$7.51/sh−228→ 18,226 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2018-03-21$25.98/sh−567→ 17,758 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-03-06+30,000→ 30,000 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2018-03-06+5,000→ 18,325 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-10-06+15,000→ 15,000 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2017-10-06+2,500→ 12,405 total

Companies

Recent Filings

Address

1 CASPER STREET

DANBURY, CT, 06810

View on SEC.gov